Partnership for Breast Care

Home/About Us
Q&As
Other Resources
How You Can Help
News/Articles
Print Documents
Contact Us
Search the Site
Breast Problems Providers Support Services Clinical Research Breast Health
Current Breast Care Trials at HH

Mestastatic Disease Clinical Trials are trials for patients whose cancer has spread beyond the breast and into the lymph nodes under the arm.

QUINTILES, INC. / TAIHO Pharmaceutical: A phase II, randomized, double-blinded efficacy and safety study of three doses of TAS-108 administered orally in postmenopausal patients with locally advanced or locally recurrent inoperable or progressive metastatic breast carcinoma following standard first line endocrine therapy.

For more information about metastatic disease trials at Hartford Hospital, please contact:

Camille A. Servodidio, RN, MPH, CRNO, OCN, CCRP - Program Coordinator, Cancer Clinical Research Office, Cancer Program- Hartford Hospital
Phone:(860) 545-5363
Email: cservod@harthosp.org

Prevention Trials

Clinical Trials
for Treatments
Combined with
Surgery (Adjuvant)


Metastatic Disease
Clinical Trials

Screening Trials

Quality of Life